The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Islet Amyloid Polypeptide (IAPP) Transgenic Rodents as Models for Type 2 Diabetes
Open accessAbstract
Blood glucose concentrations are maintained by insulin secreted from beta-cells located in the islets of Langerhans. There are approximately 2000 beta-cells per islet, and approximately one million islets of Langerhans scattered throughout the pancreas. The islet in type 2 diabetes mellitus (T2D) has deficient beta-cell mass due to increased beta-cell apoptosis and islet amyloid derived from islet amyloid polypeptide (IAPP). Accumulating evidence implicates toxic IAPP oligomers in the mediation of beta-cell apoptosis in T2D. Humans, monkeys, and cats express an amyloidogenic toxic form of IAPP and spontaneously develop diabetes characterized by islet amyloid deposits. However, longitudinal studies of islet pathology in humans are impossible, and studies in nonhuman primates and cats are costly and impractical. Rodent IAPP is not amyloidogenic, thus commonly used rodent models of diabetes do not recapitulate islet pathology in humans. To investigate the diabetogenic role of human IAPP (h-IAPP), several mouse models and, more recently, a rat model transgenic for h-IAPP have been developed. Studies in these models have revealed that the toxic effect of h-IAPP on beta-cell apoptosis demonstrates a threshold-dependent effect. Specifically, increasing h-IAPP transgene expression by breeding or induction of insulin resistance leads to increased beta-cell apoptosis and diabetes. These transgenic rodent models for h-IAPP provide an opportunity to elucidate the mechanisms responsible for h-IAPP-induced beta-cell apoptosis further and to test novel approaches to the prevention and treatment of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current consensus in the literature is that extracellular plaques of IAPP are not causative of beta-cell pathology, but rather intracellular oligomers of this protein observed in T2D patients (but not in T2D-free individuals) produce the cytotoxic effects.128,131”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H. O. M., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,294
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Self-citationChen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., Lakey, N. D., Culpepper, J., More, K. J., Breitbart, R. E., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81294-5 · Cited by 2,214
Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men
Chan, J. M., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.961 · Cited by 1,808
Fatty acid-induced β cell apoptosis: A link between obesity and diabetes
Shimabukuro, M., Zhou, Y.-T., Levi, M., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2498 · Cited by 1,142
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,113
Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Emerging epidemic of type 2 diabetes in youth
Rosenbloom, A. L., Joe, J. R., Young, R. S., & Winter, W. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.345 · Cited by 1,019 · cited 1×
“Whereas T2D used to be a disease of midlife or old age, it is increasingly seen in children and young adults (Fagot-Campagna et al. 2001; Rosenbloom et al. 1999).”
MethodGlucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,006
Lee, Y., Hirose, H., Ohneda, M., Johnson, J. H., McGarry, J., & Unger, R. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10878 · Cited by 832
Leptin receptor missense mutation in the fatty Zucker rat
Phillips, M. S., Liu, Q., Hammond, H. A., Dugan, V., Hey, P. J., Caskey, C. T., & Hess, J. F. (1996) · Nature Genetics · doi:10.1038/ng0596-18 · Cited by 822
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Lorenzo, A., Razzaboni, B. L., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 820
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.
Westermark, P., Engström, U., Johnson, K. H., Westermark, G. T., & Betsholtz, C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5036 · Cited by 807
Janson, J., Ashley, R. H., Harrison, D. J., McIntyre, S., & Butler, P. C. (1999) · Diabetes · doi:10.2337/diabetes.48.3.491 · Cited by 614
Self-citationPick, A., Clark, J., Kubstrup, C., Levisetti, M., Pugh, W., Bonner-Weir, S., & Polonsky, K. S. (1998) · Diabetes · doi:10.2337/diabetes.47.3.358 · Cited by 551
Cnop, M., Hannaert, J. C., Hoorens, A., Eizirik, D. L., & PIPELEERS, D. G. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1771 · Cited by 548
Wei, M., Gaskill, S. P., Haffner, S., & Stern, M. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1167 · Cited by 515
Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111542 · Cited by 483
Butler, A. E., Janson, J., Soeller, W. C., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2304 · Cited by 411
Self-citationDonath, M. Y., Gross, D. J., Cerasi, E., & Kaiser, N. (1999) · Diabetes · doi:10.2337/diabetes.48.4.738 · Cited by 405
β-Cell Mass Dynamics in Zucker Diabetic Fatty Rats
Finegood, D. T., McArthur, M. D., Kojwang, D., Thomas, M. J., Topp, B. G., Leonard, T. B., & Buckingham, R. E. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1021 · Cited by 375
Boscaro, M., Barzon, L., Fallo, F., & Sonino, N. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04172-6 · Cited by 344
Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.
Janson, J., Soeller, W. C., Roche, P. C., Nelson, R. T., Torchia, A. J., Kreutter, D. K., & Butler, P. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7283 · Cited by 343
Self-citationEffects of Meal Ingestion on Plasma Amylin Concentration in NIDDM and Nondiabetic Humans
Butler, P. C., Chou, J., Carter, W. B., Wang, Y.-N., Bu, B.-H., Chang, D., Chang, J.-K., & Rizza, R. A. (1990) · Diabetes · doi:10.2337/diab.39.6.752 · Cited by 330
Self-citationHigh Prevalence of Hepatitis C Virus Infection in Diabetic Patients
Simó, R., Hernández, C., Genescà, J., Jardí, R., & Mesa, J. (1996) · Diabetes Care · doi:10.2337/diacare.19.9.998 · Cited by 273
Butler, A. E., Jang, J., Gurlo, T., Carty, M. D., Soeller, W. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1509 · Cited by 267
Self-citationInsulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action
Hansen, I. B., Tsalikian, E., Beaufrère, B., Gerich, J. E., Haymond, M. W., & Rizza, R. A. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.250.3.e269 · Cited by 215
Increased Islet Volume but Unchanged Islet Number in ob/ob Mice
Bock, T. G., Pakkenberg, B., & Buschard, K. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1716 · Cited by 188
Ohsawa, H., Kanatsuka, A., Yamaguchi, T., Makino, H., & Yoshida, S. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92529-1 · Cited by 186
Fagot‐Campagna, A., SAADDINE, J. B., Flegal, K. M., & Beckles, G. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.834 · Cited by 168
Movassat, J., Saulnier, C., Serradas, P., & Portha, B. (1997) · Diabetologia · doi:10.1007/s001250050768 · Cited by 157
Initiation of Increased Pancreatic Islet Growth in Young Normoglycemic Mice (Umea +/?)
Edvell, A., & Lindström, P. (1999) · Endocrinology · doi:10.1210/endo.140.2.6514 · Cited by 156
Alteration of Islet Cell Populations in Spontaneously Diabetic Mice
Baetens, D., Stefan, Y., Ravazzola, M., MALAISSE-LAGAE, F., Coleman, D., & Orci, L. (1978) · Diabetes · doi:10.2337/diab.27.1.1 · Cited by 155
Höppener, J. W. M., Oosterwijk, C., Nieuwenhuis, M. G., Posthuma, G., Thijssen, J. H. H., Vroom, T. M., Ahrén, B., & Lips, C. J. M. (1999) · Diabetologia · doi:10.1007/s001250051175 · Cited by 153
Longitudinal studies on the development of diabetes in individual Macaca nigra
Howard, C. F. (1986) · Diabetologia · doi:10.1007/bf00452067 · Cited by 141
Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide.
Soeller, W. C., Janson, J., Hart, S. E., Parker, J. C., Carty, M. D., Stevenson, R. W., Kreutter, D. K., & Butler, P. C. (1998) · Diabetes · doi:10.2337/diabetes.47.5.743 · Cited by 140
Self-citationHarmon, J. S., Gleason, C. E., Tanaka, Y., Poitout, V., & Robertson, R. P. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2481 · Cited by 140
Betsholtz, C., Svensson, V., Rorsman, F., Engström, U., Westermark, G. T., Wilander, E., Johnson, K. H., & Westermark, P. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90407-2 · Cited by 125
O’Brien, T. D., Butler, P. C., Westermark, P., & Johnson, K. H. (1993) · Veterinary Pathology · doi:10.1177/030098589303000401 · Cited by 117
Self-citationReplication Increases β-Cell Vulnerability to Human Islet Amyloid Polypeptide-Induced Apoptosis
Ritzel, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1701 · Cited by 115
Self-citationHull, R. L., Andrikopoulos, S., Verchere, C. B., Vidal, J., Wang, F., Cnop, M., Prigeon, R. L., & Kahn, S. E. (2003) · Diabetes · doi:10.2337/diabetes.52.2.372 · Cited by 109
Shafrir, E., Ziv, E., & Mosthaf, L. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07798.x · Cited by 106
Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice
Kawasaki, F., Matsuda, M., Kanda, Y., Inoue, H., & Kaku, K. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00128.2004 · Cited by 99
Islet Amyloid Polypeptide in Human Insulinomas: Evidence for Intracellular Amyloidogenesis
O’Brien, T. D., Butler, A. E., Roche, P. C., Johnson, K. H., & Butler, P. C. (1994) · Diabetes · doi:10.2337/diab.43.2.329 · Cited by 94
Self-citationPortha, B., Giroix, M.-H., Serradas, P., Gangnerau, M.-N., Movassat, J., Rajas, F., Bailbé, D., Plachot, C., Mithieux, G., & Marie, J. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s89 · Cited by 93
Couce, M., Kane, L. A., O’Brien, T. D., Charlesworth, J. E., Soeller, W. C., McNeish, J. D., Kreutter, D. K., Roche, P. C., & Butler, P. C. (1996) · Diabetes · doi:10.2337/diab.45.8.1094 · Cited by 91
Self-citationSTUDIES ON THE PATHOGENESIS OF DIABETES IN ACROMEGALY
Luft, R., Cerasi, E., & Hamberger, C. A. (1967) · European Journal of Endocrinology · doi:10.1530/acta.0.0560593 · Cited by 81
Wang, F., Hull, R. L., Vidal, J., Cnop, M., & Kahn, S. E. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2514 · Cited by 77
Picarel-Blanchot, F., Lubrano-Berthelier, C., Bailbé, D., & Portha, B. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.4.e755 · Cited by 76
Pancreatic Islets of Obese Hyperglycemic Mice (ob/ob)
Tomita, T., Doull, V., POLLOCK, H. G., & Krizsan, D. (1992) · Pancreas · doi:10.1097/00006676-199205000-00015 · Cited by 75
Diabetes mellitus in pancreatic cancer follow-up.
Fogar, P., Pasquali, C., Basso, D., Sperti, C., Panozzo, M. P., Tessari, G., D'Angeli, F., Favero, G. D., & Plebani, M. (1994) · PubMed · Cited by 72
Shafrir, E., & Gutman, A. (1993) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.1993.4.1-2.83 · Cited by 65
Comparison of Body Size Measurements as Predictors of NIDDM in Pima Indians
Warne, D. K., Charles, M.-A. A., Hanson, R. L., Jacobsson, L., McCance, D. R., Knowler, W. C., & Pettitt, D. J. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.435 · Cited by 56
Yagui, K., Yamaguchi, T., Kanatsuka, A., Shimada, F., Huang, C. I., Tokuyama, Y., Ohsawa, H., Yamamura, K., Miyazaki, J., Mikata, A., et al. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320487 · Cited by 53
Initiation of Increased Pancreatic Islet Growth in Young Normoglycemic Mice (Umea +/?)
Edvell, A. (1999) · Endocrinology · doi:10.1210/en.140.2.778 · Cited by 44
Åhrén, B., Oosterwijk, C., Lips, C. J. M., & Höppener, J. W. M. (1998) · Diabetologia · doi:10.1007/s001250051079 · Cited by 43
Human Islet Amyloid Polypeptide Accumulates at Similar Sites in Islets of Transgenic Mice and Humans
de Koning, E. J. P., Höppener, J. W. M., Verbeek, J. S., Oosterwijk, C., van Hulst, K. L., Baker, C. A., Lips, C. J. M., Morris, J. F., & Clark, A. (1994) · Diabetes · doi:10.2337/diab.43.5.640 · Cited by 42
The role of amylin in the insulin resistance of non-insulin-dependent diabetes mellitus
Leighton, B., & Cooper, G. J. S. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90015-4 · Cited by 41
Perseghin, G., Caumo, A., Arcelloni, C., Benedini, S., Lanzi, R., Pagliato, E., Sereni, L. P., Testolin, G., Battezzati, A., Comı, G., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2112 · Cited by 40
Sando, H., LEE, Y. S., Iwamoto, Y., Ikeuchi, M., & Kosáka, K. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-5-1143 · Cited by 37
Imaging β-Cell Death With a Near-Infrared Probe
Medarova, Z. O., Bonner‐Weir, S., Lipes, M. A., & Moore, A. V. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1780 · Cited by 33
Tedstone, A. E., Nezzer, T., Hughes, S. J., Clark, A., & Matthews, D. R. (1990) · Bioscience Reports · doi:10.1007/bf01117233 · Cited by 31
Postmortem Autolysis in the Pancreas
Shimizu, M., Hayashi, T., Saitoh, Y., Ohta, K., & Itoh, H. (1990) · Pancreas · doi:10.1097/00006676-199001000-00013 · Cited by 30
徳山, 竜., Yagui, K., Yamaguchi, T., Huang, C. I., Kuramoto, N., Shimada, F., Miyazaki, J., Horie, H., Saitō, Y., Makino, H., et al. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90276-6 · Cited by 26
Hull, R. L., Watts, M. R., Kodama, K., Shen, Z.-P., Utzschneider, K. M., Carr, D. B., Vidal, J., & Kahn, S. E. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2004 · Cited by 12
Diabetes Mellitus and Preventable Spinal Cord Injury
Frisbie, J. H. (2005) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2005.11753799 · Cited by 11
Flagged first, then by citations
Research works printed but not linked: 5
- 2001, ADOLESCENTS THE THIRD NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY DIABETES CARE, 24, 834
- Fogar, 1994, Anticancer Research, 14, 2827
- 1986, American Journal of Physiology -- Legacy Content, 250, E269
- 1996, American Journal of Physiology -- Legacy Content, 271, E755
- 1990, THE INFLUENCE OF CLINICOPATHOLOGICAL CONDITIONS PANCREAS, 5, 91
Cited by
Sorted by citations
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
Biessels, G. J., & Despa, F. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0048-7 · Cited by 1,454
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
The use of animal models in diabetes research
King, A. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01911.x · Cited by 1,303
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 624
Self-citation
Metadata
- Authors
- Matveyenko, A. V., & Butler, P. C.
- Affiliations
- University of California, Los Angeles (US)
- Venue
- ILAR Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-01
- Volume
- 47
- Issue
- 3
- Pages
- 225-233
- ISSN
- 1084-2020 (ISSN-L)
- OpenAlex
- W2139785451
- Cited by
- 150
- References
- 68
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 5 · 2023: 8 · 2022: 5 · 2021: 12 · 2020: 7 · 2019: 6 · 2018: 13 · 2017: 9 · 2016: 8 · 2015: 8 · 2014: 7 · 2013: 5 · 2012: 9
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- ILAR Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Larry L. Hillblom Foundation
- Pfizer
- National Institutes of Health
- University of California, Los Angeles
- U.S. Public Health Service
- National Institute of Diabetes and Digestive and Kidney Diseases (DK59579, R01DK059579)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- amylin, type 2 diabetes, transgenic rodent models, beta-cell apoptosis, beta-cell mass, insulin resistance
- MeSH terms
- Amyloid, Animals, Diabetes Mellitus, Type 2, Disease Models, Animal, Humans, Mice, Transgenic, Insulin-Secreting Cells, Mice, Rats, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
